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Down syndrome (DS) is associated with significant perturbances in
mitochondrial function. Here we tested the hypothesis that the
suppression of mitochondrial electron transport in DS cells is due to
high expression of cystathionine-β-synthase (CBS) and subsequent
overproduction of the gaseous transmitter hydrogen sulfide (H2S).
Fibroblasts from DS individuals showed higher CBS expression than
control cells; CBS localization was both cytosolic and mitochondrial.
DS cells produced significantly more H2S and polysulfide and exhibited
a profound suppression of mitochondrial electron transport, oxygen
consumption, and ATP generation. DS cells also exhibited slower
proliferation rates. In DS cells, pharmacological inhibition of CBS
activity with aminooxyacetate or siRNA-mediated silencing of CBS
normalized cellular H2S levels, restored Complex IV activity, improved
mitochondrial electron transport and ATP synthesis, and restored cell
proliferation. Thus, CBS-derived H2S is responsible for the suppression
of mitochondrial function in DS cells. When H2S overproduction is
corrected, the tonic suppression of Complex IV is lifted, andmitochon-
drial electron transport is restored. CBS inhibition offers a potential
approach for the pharmacological correction of DS-associated mito-
chondrial dysfunction.
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Down syndrome (DS)—trisomy of human chromosome 21(HSA21)—remains the most common chromosomal disor-
der (1). It is associated with significant perturbances in many
morphological and biochemical features. One of its biochemical
hallmarks is mitochondrial dysfunction. Suppression of mitochon-
drial function—including inhibition of mitochondrial Complex IV—
has been documented in cells from DS individuals (DSCs) (2).
Complex IV is an essential electron transport component; its
best-characterized inhibitors include cyanide (an irreversible inhibi-
tor) and hydrogen sulfide (H2S) (a reversible inhibitor) (3).
H2S is an endogenous mammalian gaseous mediator, which
regulates many cellular processes including mitochondrial func-
tion (4). Its effects are often bell shaped: At lower concentra-
tions H2S stimulates cellular bioenergetics, while at toxicological
concentrations H2S suppresses mitochondrial function via inhi-
bition of Complex IV (4). Cystathionine-β-synthase (CBS)—
located on HSA21—is a principal enzyme responsible for H2S
production. Overexpression of CBS (5) and increased levels of
the H2S metabolite thiosulfate (6) were previously reported in
DS. We have now directly tested the hypothesis whether the
excess H2S produced by CBS is responsible for the suppression
of mitochondrial electron transport in DSCs.
DSCs exhibited markedly higher CBS expression than the healthy
control cells (CCs). CBS was both cytosolically and mitochondrially
localized (Fig. 1 A–C). The expression of various H2S metabolizing
enzymes was unaffected by DS (Fig. 1B). DSCs produced signifi-
cantly more H2S—as well as reactive polysulfides—than CCs (Fig.
1D). The increased CBS expression in DSCs was associated with a
profound suppression of cell proliferation, mitochondrial elec-
tron transport, oxygen consumption, Complex IV activity, and
ATP generation (Fig. 1 E–G).
Pharmacological inhibition of CBS with aminooxyacetate (AOAA)
(3 μM) (4) normalized H2S production (Fig. 1D), restored Com-
plex IV activity (Fig. 1G), improved mitochondrial electron
transport (Fig. 1F), and restored DSC proliferation (Fig. 1E). The
H2S-releasing molecule GYY4137 (4) phenocopied the effect of
DS in CCs in terms of bioenergetics and proliferation and re-
versed the beneficial effects of AOAA in DSCs (Fig. 1 E–G).
SiRNA-mediated silencing of CBS in DSCs recapitulated the ef-
fects of AOAA (Fig. 1 I–L).
The expression of electron transport chain proteins that are
part of Complexes II, III, and IV was increased in DSCs (Fig.
1M), likely representing a compensatory response.
CBS, a key enzyme in the transsulfuration pathway, catalyzes
the conversion of homocysteine into cystathionine (7). Lejeune
(8) has already hypothesized in the 1990s that the overdosage of
CBS may contribute to the metabolic alterations and overall
clinical picture in DS. Both the footprint of excess CBS (low
homocysteine) and the footprint of mitochondrial inhibition
(accumulation of Krebs cycle intermediaries) have been dem-
onstrated by metabolomic analysis of DS subjects (9). Moreover,
increased urinary thiosulfate and circulating sulfhemoglobin levels
have previously been reported in subjects with DS (6). The current
report confirms and extends these findings: DSCs contain higher
levels of H2S (as well as reactive polysulfides) than CCs.
The hypothesis that CBS-derived H2S may be responsible for
the metabolic suppression in DS was originally put forward by
Kamoun et al. in 2003 (6), but it has not been tested experi-
mentally until now. Our data indicate that CBS-derived H2S is,
indeed, responsible for the suppression of mitochondrial func-
tion in DSCs. When CBS activity or CBS expression is normal-
ized, the H2S-mediated tonic suppression of Complex IV is
lifted, and the cells regain their ability to perform mitochondrial
oxidative phosphorylation (Fig. 1N). In contrast to DSCs, in CCs
(which are not under the tonic suppressive effect of high H2S),
CBS inhibition does not significantly affect proliferation or
bioenergetics (Fig. 1N).
H2S-mediated suppression of cellular bioenergetics provides a
plausible mechanistic explanation for a host of characteristic
biochemical and clinical features associated with DS, including
the reduced tissue and whole-body O2 consumption and im-
paired metabolic fitness—characteristic features of DS (1)—
since these processes are directly related to mitochondrial ATP
production.
CBS overexpression was recently found to phenocopy the DS-
like neurocognitive deficits in mice (10). It is conceivable that
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Fig. 1. CBS-derived H2S is responsible for the suppression of mitochondrial function in DSCs. DSCs exhibit markedly higher CBS expression—which is, in part, localized
to the mitochondria—than healthy CCs, shown by (A) Western blotting and (C) confocal microscopy. (Scale bar: 5 μm.) (B) TST and ETHE1 expression was similar in DSCs
and CCs. (D) DSCs contain increased amounts of intracellular H2S and polysulfide. Top photomicrographs: AzMC-based H2S live cell imaging. (Scale bar: 20 μm.) (E) DSCs exhibit
reduced cell proliferation rate; this is normalized byAOAA (3 μM); treatment of CCswith theH2S donor GYY4137 (3mM) phenocopies the inhibition of proliferation seen in DSCs.
(F) DSCs exhibit low basal andmaximal mitochondrial oxygen consumption rates (OCR); these parameters are improved by AOAA; exposure of CCs to GYY4137 phenocopies the
metabolic suppression seen in DSCs. (G) Complex IV is blocked in DSCs but it is restored by AOAA. (H–L) SiRNA-mediated silencing of CBS in DSCs (H) suppresses H2S production (I),
normalizes DSC proliferation (J), and enhances OCR (K) and Complex IV activity (L). (M) Increased expression of various mitochondrial proteins belonging to electron chain
transport Complexes II, III, and IV in DSCs. (N) Bell-shaped cellular bioenergetic role of H2S in DSCs vs. CCs; effect of CBS inhibition. *P < 0.05 and **P < 0.01, significant difference
between CCs and DSCs; #P < 0.05 and ##P < 0.01, significant effect of AOAA in DSCs; §P < 0.05, significant effect of GYY4137 in CCs or significant difference between AOAA and
GYY4137+AOAA in DSCs. Data are shown as mean ± SEM of at least 3 experiments. One- and 2-way ANOVAs were performed, followed by a post hoc Bonferroni test.
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H2S overproduction and consequent inhibition of mitochondrial
Complex IV explain some of the neurological and neurocognitive
deficits associated with DS, because neurons heavily depend on
ATP produced by oxidative phosphorylation.
Importantly, H2S-mediated inhibition of Complex IV is a re-
versible biochemical process. Therefore, follow-up studies should
be conducted to determine whether pharmacological inhibition of
CBS reverses some of the functional defects associated with DS
in vivo. Several classes of CBS inhibitors exist that may be useful
for such efforts—including AOAA (which has been in clinical
trials in the 1970s), various AOAA prodrugs, natural-product
CBS inhibitors (apigenin), and benserazide (a clinically approved
drug that has a secondary pharmacological effect as a CBS
inhibitor) (4).
Materials and Methods
Female dermal fibroblasts from control (Detroit 551; ATCC CCL-110) and
DS (Detroit 539; ATCC CRL-84) subjects were obtained from LGC Standards
and cultured in Advanced DMEM. CBS silencing was achieved by siCBS
(SASI_Hs01_00214623) (Sigma). Proliferationwas quantified by BrdU (11). H2S
and polysulfide production were measured using 7-azido-4-methylcoumarin
(AzMC) (12) and 3′,6′-di(O-thiosalicyl)fluorescein (SSP4) (13), respectively.
Western blotting was performed using the iBlot 2 Dry Blotting System (11).
Mitochondrial localization of CBS was performed by confocal microscopy
with an anti-CBS antibody and MitoSOX Red (14) using a Leica TCS SP5
confocal microscope. Bioenergetic measurements were performed by ex-
tracellular flux analysis. Complex IV activity was measured in permeabilized
cells using ascorbate and TMPD (15).
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